Vaccinex, Inc. Capital Expenditures Incurred but Not yet Paid
Vaccinex, Inc. (VCNX) reported Capital Expenditures Incurred but Not yet Paid of $7.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2022-11-14
- Vaccinex, Inc. capital expenditures incurred but not yet paid for the quarter ending 2020-12-31 was $0.00.
- Vaccinex, Inc. capital expenditures incurred but not yet paid for the quarter ending 2020-09-30 was $0.00.
- Vaccinex, Inc. capital expenditures incurred but not yet paid for the quarter ending 2020-06-30 was $0.00.
- Vaccinex, Inc. capital expenditures incurred but not yet paid for the quarter ending 2020-03-31 was $161.00K.
- Vaccinex, Inc. capital expenditures incurred but not yet paid for fiscal 2020 was $161.00K, a 0.00% change from fiscal 2019.
- Vaccinex, Inc. capital expenditures incurred but not yet paid for fiscal 2019 was $161.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2021-09-30 | $7.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 derived: sum of 3 quarters · filed 2022-03-31 | $161.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $161.00K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $161.00K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $161.00K 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | $161.00K 10-K · filed 2021-03-31 | |||
| 2018-09-30 | $52.00K 10-Q · filed 2019-11-12 | |||
| 2018-03-31 | $9.00K 10-Q · filed 2019-05-15 |